Profil
Arturo Yudelevich was the founder of Andes Biotechnologies SA (founded in 2008) where he held the title of Director.
He is also the founder of Grupo Bios SA. Currently, Dr. Yudelevich holds the title of Professor at both Pontificia Universidad Católica de Chile and the University of Chile.
Dr. Yudelevich's education history includes an undergraduate degree from the University of Chile and a doctorate degree from Albert Einstein College of Medicine, Inc.
Aktive Positionen von Arturo Yudelevich
| Unternehmen | Position | Beginn |
|---|---|---|
| Grupo Bios SA | Gründer | - |
| University of Chile | Corporate Officer/Principal | - |
| Pontificia Universidad Católica de Chile | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Arturo Yudelevich
| Unternehmen | Position | Ende |
|---|---|---|
Andes Biotechnologies SA
 Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | Gründer | - |
Ausbildung von Arturo Yudelevich
| University of Chile | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | Health Technology |
| Grupo Bios SA |
